In the BioHarmony Drug Report Database

"Preview" Icon

Eftrenonacog alfa

Alprolix (eftrenonacog alfa) is a fusion protein pharmaceutical. Eftrenonacog alfa was first approved as Alprolix on 2016-05-12. It has been approved in Europe to treat hemophilia b.

 

Trade Name

 

Alprolix
 

Common Name

 

eftrenonacog alfa
 

ChEMBL ID

 

CHEMBL4594598
 

Indication

 

hemophilia b
 

Drug Class

 

Fc fusion protein

Image (chem structure or protein)

Eftrenonacog alfa structure rendering